Annual report which provides a comprehensive overview of the company for the past year. 2021-22 Annual Report(PDF,10.2MB) 2020-21 Annual Report(PDF,17MB) 2019-20 Annual Report(PDF,6.5MB) 2018-19 Annual Report(PDF,5MB) 2017-18 Annual Report(PDF,3.3MB) 2016-17 Annual Report(PDF,9.5MB) 2015-16 Annual Report(PDF,4.1MB) 2014-15 Annual Report(PDF,4.1MB) 2013-14 Annual . First-quarter sales increased 7.6 percenton a reported basis and 5.7 percent on an organic basis, excluding COVID-19 testing-related sales. The increase in Net cash from operating activities in 2021 was primarily due to the favorable cash flow impact of higher segment operating earnings and improved working capital management partially offset by higher cash taxes paid and the net impact of litigation settlements. First Edition . Get a detailed Sensex annual report of Abbott India on stock/share exchange market for the financial 2021 and more at Moneycontrol.com Inside Abbott Laboratories's 10-K Annual Report: Financial - Cash Flow Highlight. 2 See definitions and reconciliation of non-GAAP measures to GAAP measures on pages 74-83 of the Annual Report. Economic, competitive, governmental, technological and other factors that may affect Abbott's operations are discussed in Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the year ended Dec. 31, 2020, and are incorporated herein by reference. Other primarily relates to the impairment of an investment. 2022 Proxy Statement 1.7 MB. from 8 AM - 9 PM ET. Form Description. 2019 Annual Report. Established Pharmaceuticals sales increased 2.5 percent on a reported basis in the first quarter and increased 6.2 percent on an organic basis. Second-quarter sales of $10.2 billion increased 39.5 percent on a reported basis and 35.0 percent on an organic basis, which excludes the impact of foreign exchange. Cision Distribution 888-776-0942 In Pediatric Nutrition, sales growth was negatively impacted by a difficult comparison versus the first quarter of 2020 when consumers increased purchases in advance of stay-at-home directives as a result of COVID-19. Note: In order to compute results excluding the impact of exchange rates, current year U.S. dollar sales are multiplied or divided, as appropriate, Environmental, Social and Governance (ESG), HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American. 2020 Proxy Statement 881.8 KB. Associated British Foods is a diversified group, with a wide range of food and ingredient businesses as well as our flagship retail brand, Primark. 2021 Global Sustainability Report Summary. ABBOTT PAKISTAN ANNUAL REPORT 2021. REQUEST PRINTED MATERIALS To request information via email, please follow this link; INVESTOR CONTACTS Learn how to . Strong growth in the quarter was driven by demand for Abbott's portfolio of COVID-19 diagnostics tests across its rapid and lab-based platforms. Current Performance Report First Edition 2022. ABBOTT PARK, Ill., July 22, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2021. Read more about Abbott's Annual Reports. Financial - Earnings Highlight. You are . It provides comprehensive information on the company and its strategy, business, governance and financial performance. Abbott's FreeStyle Libre is Named Best Medical Technology in Abbott Reports Third-Quarter 2022 Results and Raises Full-Year Abbott projects full-year 2021 diluted EPS from continuing operations on a GAAP basis of at least, Global COVID-19 testing-related sales were. CONTACT ABBOTT INDIA ABOUT US ABOUT US. Seetables titled "Details of Specified Items"for additional details regarding specified items. By staying here you are agreeing to our use of cookies. Abbott issues full-year 2021 guidance for diluted EPS from continuing operations on a GAAP basis of at least $3.74 and full-year Download DOC. 53 Listing Rules of SIX Swiss Exchange. - Sales growth of 35.3 percent; organic sales growth of 32.9 percent, - GAAP diluted EPS growth from continuing operations of 233.3 percent; adjusted diluted EPS growth of 103.1 percent, - All four major businesses achieved strong sales growth in the quarter, - Projected full-year EPS remains unchanged; reflects growth of more than 35 percent. . First-quarter sales of $10.5 billion. adjusted diluted EPS from continuing operations of at least $5.00, reflecting growth of more than 35 percent versus the prior year. Annual Report 2021. It will be distributed when it becomes available. First Edition 2020. ABBOTT LABORATORIES. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. Reflects the net tax benefit associated with the specified items and excess tax benefits associated with share-based compensation. Abbott forecasts specified items for the full-year 2021 of $1.26 primarily related to intangible amortization, expenses associated with acquisitions, restructuring and cost reduction initiatives and other net expenses. Corporate governance (including Board and Executive Committee). Excluding COVID-19 testing-related sales, Core Laboratory Diagnostics sales increased 10.7 percent and Molecular Diagnostics sales increased 31.5 percent on an organic basis in the first quarter.3, Established Pharmaceuticals($ in millions). Company. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. View HTML. Global COVID-19 testing-related sales were $2.2 billion in the first quarter, led by combined sales of $1.8 billion from Abbott's BinaxNOW, Panbio and ID NOW rapid testing platforms. Message Following are sales by business segment and commentary for the first quarter 2021: * Total Q1 2021 Abbott sales from continuing operations include Other Sales of approximately $16 million. Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables wereremoved, added and changedby Abbott Laboratories. Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance Sales growth of 10.1 percent; organic sales growth of 14.3 percent GAAP diluted EPS growth of 72.7 percent; adjusted diluted EPS growth of 22.2 percent Global COVID-19 testing-related sales of $2.3 billion in the second quarter Document Date. Abbott Laboratories (ABT) SEC Filing 10-Q Quarterly Report for the period ending Friday, September 30, 2022 . Abbott India Limited . e m pl oye r i de nt i fi c a t i on num be r) (224) 667-6100 (t e l e phone num be r) Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more, Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports, Consolidated Balance Sheet (Parenthetical), Consolidated Statement Of Comprehensive Income, Consolidated Statement Of Comprehensive Income (Parenthetical), Consolidated Statement Of Shareholders' Investment, Consolidated Statement Of Shareholders' Investment (Parenthetical), Accumulated Other Comprehensive Income (Loss), Accumulated Other Comprehensive Income (Loss) (Details), Accumulated Other Comprehensive Income (Loss) (Tables), Debt And Lines Of Credit - Debt Issuances And Redemptions (Details), Debt And Lines Of Credit - Principal Payments (Details), Debt And Lines Of Credit - Schedule (Details), Debt And Lines Of Credit - Weighted-Average Interest Rate (Details), Discontinued Operations And Business Dispositions, Discontinued Operations And Business Dispositions - Summary (Details), Financial Instruments, Derivatives And Fair Value Measures, Financial Instruments, Derivatives And Fair Value Measures (Tables), Financial Instruments, Derivatives And Fair Value Measures - Bases Of Measurement (Details), Financial Instruments, Derivatives And Fair Value Measures - Carrying Value And Fair Value (Details)K, Financial Instruments, Derivatives And Fair Value Measures - Contracts (Details), Financial Instruments, Derivatives And Fair Value Measures - Gain Or Loss (Details), Financial Instruments, Derivatives And Fair Value Measures - Location Of Derivative Instruments (Details), Goodwill And Intangible Assets - Goodwill (Details), Goodwill And Intangible Assets - Intangible Assets (Details), Incentive Stock Program - Expense (Details), Incentive Stock Program - Options Fair Value (Details), Incentive Stock Program - Restricted Awards And Units (Details), Incentive Stock Programs - General (Details), Incentive Stock Programs - Option Activity (Details), Lease - Lessor Lease Description (Details), Leases - Amounts And Location Of Operating Lease Rou Assets And Lease Liabilities (Details), Leases - Future Minimum Lease Payments (Details), Leases - Operating Leases As Lessee (Details), Litigation And Environmental Matters (Details), Post-Employment Benefits - Assets (Details), Post-Employment Benefits - Assumptions (Details), Post-Employment Benefits - Benefit Obligation (Details), Post-Employment Benefits - Expense (Details), Post-Employment Benefits - Funding And Payments (Details), Post-Employment Benefits - Stock Retirement Plan (Details), Revenue - Assets Recognized For Costs To Obtain A Contract With A Customer (Details), Revenue - Other Contract Assets And Liabilities (Details), Revenue - Remaining Performance Obligations (Details), Schedule Ii Valuation And Qualifying Accounts, Schedule Ii Valuation And Qualifying Accounts (Details), Segment And Geographic Area Information (Tables), Segment And Geographic Area Information - Depreciation And Assets (Details), Segment And Geographic Area Information - Geographic Information (Details), Segment And Geographic Area Information - Reconciliation (Details), Segment And Geographic Area Information - Sales And Earnings (Details), Summary Of Significant Accounting Policies, Summary Of Significant Accounting Policies (Policies), Summary Of Significant Accounting Policies (Tables), Summary Of Significant Accounting Policies - Cash, Cash Equivalents And Investments (Details), Summary Of Significant Accounting Policies - Earnings Per Share (Details), Summary Of Significant Accounting Policies - Pensions (Details), Summary Of Significant Accounting Policies - Property And Equipment (Details), Supplemental Financial Information (Tables), Supplemental Financial Information - Acquired R&Amp;D (Details), Supplemental Financial Information - Allowance For Doubtful Accounts (Details), Supplemental Financial Information - Investments (Details), Supplemental Financial Information - Other Accrued Liabilities (Details), Supplemental Financial Information - Other Income And Expense (Details), Supplemental Financial Information - Post-Employment Obligations And Other Long-Term Liabilities (Details), Taxes On Earnings From Continuing Operations, Taxes On Earnings From Continuing Operations (Details), Taxes On Earnings From Continuing Operations (Tables), Taxes On Earnings From Continuing Operations - Deferred Tax Assets And Liabilities (Details), Taxes On Earnings From Continuing Operations - Earnings And Taxes (Details), Taxes On Earnings From Continuing Operations - Tax Rate Reconciliation (Details), Taxes On Earnings From Continuing Operations - Unrecognized Tax Benefits (Details), Exhibit 21: Subsidaries Of The Registrant, Exhibit 23.1: Consents Of Experts And Counsel, Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification, Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification, https://last10k.com/sec-filings/abt/0001104659-21-025751.htm. With a history of excellence stretching back more than 130 years, ABBs success is driven by about 105,000 talented employees in over 100 countries. Annual report which provides a comprehensive overview of the company for the past year. By staying here you are agreeing to our use of cookies. Share Department Telephone Numbers 021-38709516 021-38709222. The increase in Net cash from operating activities in 2021 was primarily due to the favorable cash flow impact of higher segment operating earnings and improved working capital management partially offset by higher cash taxes paid and the net impact of litigation settlements. Net Debt/EBITDA. Non-GAAP Reconciliation of Financial Information From Continuing Operations, Diluted Earnings per Share from Continuing Operations. Second-quarter sales of $10.2 billion. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product . ABBOTT LABORATORIES . . "We're off to a very strong start to the year, with all four of our major businesses achieving strong growth," said Robert B. Ford, president and chief executive officer, Abbott. Second Edition 2020 . The meeting will be held on April 23, 2021, at Abbott's headquarters, 100 Abbott Park Road, at the intersection of Route 137 and Waukegan Road, Lake County, Illinois. The operating margin profile decreased from 30.8 percent of sales in 2019 to 25.8 percent in 2020 primarily due to lower sales and manufacturing volumes as a result of the pandemic and pricing pressures on drug eluting stents (DES) as a result of market competition in the U.S. and other major markets. ABBOTT PARK, Ill., April 20, 2021 /PRNewswire/ -- Abbott(NYSE: ABT)today announced financial results for the first quarter ended March 31, 2021. Second Edition 2017. Abbott will live webcast its first-quarter earnings conference call through its Investor Relations website at www.abbottinvestor.comat 8:30 a.m. Central time today. Worldwide Nutrition sales increased 6.9 percent on a reported basis and 6.4 percent on an organic basis in the first quarter. ABBOTT DECLARES 389THCONSECUTIVE QUARTERLY DIVIDEND On Feb. 19, 2021, the board of directors of Abbott declared the company's quarterly dividend of $0.45 per share. Acquisition-related expenses include integration costs, which represent incremental costs directly related to integrating the acquired businesses and include expenditures for the integration of systems, processes and business activities. Fourth-quarter 2021 worldwide sales of $11.5 billion increased 7.2 percent on a reported basis and 7.7 percent on an organic basis. 2021 Group financial highlights. Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Abbott Laboratories. 2021 Diversity and Inclusion Report. . Organic sales growth was led by strong growth across several geographies, including China, India and Brazil. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. Restructuring and cost reduction initiative expenses include severance, outplacement, and other direct costs associated with specific restructuring plans and cost reduction initiatives. Exclusive of these discrete items, tax expense was favorably impacted by lower tax rates and tax exemptions on foreign income primarily derived from operations in Puerto Rico, Switzerland, Ireland, the Netherlands, Costa Rica, Singapore, and Malta. First Edition 2018. We are united by our purpose to provide safe, nutritious and affordable food, and clothing that is great value for money. Careers; Investors; Newsroom; Responsibility; Partners; Contact; SITE MAP; POLICIES; privacy policy; Terms & Conditions; true. Annual Filings. First Edition 2021. Other primarily relates to the net costs related to certain litigation, the acquisition of a research and development asset, and the impairment of an equity investment. Inside Abbott Laboratories's 10-K Annual Report: Financial - Earnings Highlight. Download XLS. ABBOTT PARK, Ill., April 20, 2021 /PRNewswire/ -- Abbott (NYSE: ABT ) today announced financial results for the first quarter ended March 31, 2021. ABB's website uses cookies. Abbott Laboratories - AnnualReports.com 10,000+ Employees Based in North Chicago, Illinois Most Recent Annual Report MOST RECENT 2021 Annual Report and Form 10K View PDF View Form 10K (HTML) Add Annual Report To Cart View 2021 Global Sustainability Report In the fourth quarter, global COVID-19 testing-related sales were $2.4 billion, led by combined sales of $1.9 billion from Full-year 2020 GAAP diluted EPS from continuing operations was $2.49 and adjusted diluted EPS from continuing operations was Feb 19, 2021. Abbott has increased its dividend payout for 49 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years. 2021 Annual Report 6 MB. F or the fi s c al ye ar e nde d De c e mbe r 31, 2021 Commi s s i on fi l e numbe r 1-2189 A b b ott L ab or ator i e s An I l l i noi s Cor por ati on 36-0698440 100 Abbott P ar k Road Abbott P ar k, I l l i noi s 60064-6400 (I.R .S. ABB Ltd published its 2021 annual report and filed the annual report on Form 20-F with the United States Securities and Exchange Commission, Ad hoc Announcement pursuant to Art. 1 First-quarter 2021 diluted EPS from continuing operations on a GAAP basis reflects 233.3 percent growth.2Full-year 2021 guidance for diluted EPS from continuing operations on a GAAP basis reflects growth of at least 50 percent versus the prior year. Growth Forecast for 2021. It will be distributed when it becomes available. Over the last three years, Abbott's operating margin as a percentage of sales increased from 11.9 percent in 2018 to 14.2 percent in 2019 and 15.5 percent in 2020. Sales & Development Director at Watkin Davies Insurance Consultants. 10-K Annual Report February 2021 10-K Annual Report February 2020 . Some statements in this news release may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. ABBOTT PARK, Ill., July 22, 2021 / PRNewswire / -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2021. Based in North Chicago, Illinois Most Recent Annual Report MOST RECENT 2021 Annual Report and Form 10K View PDF View Form 10K (HTML) View 2021 Global Sustainability Report This company has a Global Sustainability Report available to view on our partner site, ResponsibilityReports.com Older/Archived Annual Reports 2020 Annual Report 9 MB. Download PDF. Annual report which provides a comprehensive overview of the company for the past year, To request information via email, please follow this link, Learn how to contact our transfer agent and investor relations department, EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA, EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE, EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE, EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE, EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE. Filing Group. 2020 Net Earnings and Diluted Earnings per Common Share from Continuing Operations, excluding Specified Items, excludes net after-tax charges of $618 million, or $0.35 per share, for intangible amortization expense and other expenses primarily associated with acquisitions and restructuring actions. In 2019, interest expense, net decreased $145 million due to the favorable impact of the euro debt financing in September 2018, as well as the repayment of debt in 2018 and the first quarter of 2019. Total recommended dividend per share 3. 2021 Proxy Statement 4 MB. 4%. Second Edition 2021. Seetables titled"Details of Specified Items"for additional details regarding specified items. Fourth-quarter sales of $10.7 billion increased 28.7 percent on a reported basis and 28.4 percent on an organic basis, which Read through Abbott semi-annual reports detailing overall performance of our implantable Cardiac Rhythm Management products. Issuer. ABB (ABBN: SIX Swiss Ex) is a leading global technology company that energizes the transformation of society and industry to achieve a more productive, sustainable future. See tablestitled"Non-GAAP Reconciliation of Financial Information From Continuing Operations"for an explanation of certain non-GAAP financial information. 1 Net sales are sales less excise duties. She is Founder & CEO of Planetive, a sustainability advisory platform and runs the advisory practice of Khalid Majid Rehman Chartered Accountants as Managing When typing in this field, a list of search results will appear and be automatically updated as you type. KEY PERFORMANCE INDICATORS METHODS AND ASSUMPTIONS USED IN COMPILING THE INDICATORS A Key Performance Indicator (KPI) is a measurable value that demonstrates how effectively a company is achiev-ing its business objectives. 2021 Annual Report. Abbott Laboratories. This proxy statement and the accompanying proxy . 1w. Acquisition-related expenses include integration costs, which represent incremental costs directly related to integrating the acquired business and include expenditures for retention, severance, and the integration of systems, processes and business activities. Company. An archived edition of the webcast will be available later that day. Abbott House 2021 Annual Report - Other - Page 1; Abbott House 2021 Annual Report - Other - Page 2 Adult NutritionalRead more, In Abbott's worldwide diagnostics business,Read more, The 225.7 percent increase inRead more, Total Nutritional Products sales increasedRead more, Sales in emerging markets, whichRead more, In 2020, financing activities relatedRead more, Research and Development Process InRead more, Core Laboratory Diagnostics - AbbottRead more, In the Diagnostics segment, CoreRead more, Differences between the expected long-termRead more, While Abbott's 2020 sales wereRead more, The proceeds equated to approximatelyRead more, Any borrowings under the RevolvingRead more, Abbott periodically acquires a businessRead more, In 2019, U.S. A reconciliation of the first-quarter tax rates for continuing operations for 2021 and 2020 is shown below: Restructuringand CostReductionInitiatives (b), Tax expense on Earnings from Continuing Operations (d), The table above provides additional details regarding the specified items described on table titled "Non-GAAP Reconciliation of Financial Information From Continuing Operations.". Organic sales growth excludes the impact of foreign exchange. 2019 Annual Report 8.3 MB. Our 109,000 colleagues serve people in more than 160 countries. By connecting software to its electrification, robotics, automation and motion portfolio, ABB pushes the boundaries of technology to drive performance to new levels. Annual Report 2020-2021 Cgep John Abbott College Annual Report 2020-2021 Cgep John Abbott College 6 7. 2020 Annual Report. Second Edition 2019. Abbott Laboratories's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes: Operating margins decreased from 20.2 percent of sales in 2018 to 18.5 percent in 2020 primarily due to the unfavorable impact of foreign exchange, product mix and lower gross margins. "We exited the year with a lot of momentum and are forecasting EPS growth of more than Great to be featured in the exceptionally positive Welsh Sports Association annual report, announcing our . Condensed Consolidated Statement of Earnings, First Quarter Ended March 31, 2021 and 2020, Cost of products sold, excluding amortization expense, Earnings from Continuing Operations before taxes, Tax expense on Earnings from Continuing Operations, Earnings from Discontinued Operations, net of taxes, Earnings from Continuing Operations, excluding, Diluted Earnings per Common Share from Continuing, Operations, excluding Specified Items, as described below, Average Number of Common Shares Outstanding. 3 Excluding COVID-19 testing-related sales, Core Laboratory Diagnostics sales increased 14.1 percent and Molecular Diagnostics sales increased 33.9 percent on a reported basis in the first quarter. The 2021 annual report is now available electronically at www.abb.com/groupreports. 2021 2020. accessibility. The accompanying proxy is solicited by the Board of Directors on behalf of Abbott for use at the Annual Meeting of Shareholders. Restructuring and cost reduction plans consist of distinct initiatives to streamline operations including the consolidation and rationalization of business activities and facilities, workforce reductions, the transfer of product lines between manufacturing facilities, and the transfer of other business activities between sites. First-quarter 2021 worldwide sales of $10.5 billion increased 35.3 percent on a reported basis and 32.9 percent on an organic basis. Filing Group. Other. As at 18th September . 72.55p. ABBOTT INDIA LIMITED ANNUAL REPORT 2021-22 ENRICHING LIVES, EVERYDAY TABLE OF CONTENTS CORPORATE OVERVIEW Enriching Lives of Read more 16 Our Patients through Corporate Overview Statutory Reports Financial Statements Notice ENRICHING LIVES, EVERYDAY TRENDS IMPACTING VALUE CREATION Operating Environment Strategic Priorities Business Model ESG FreeStyle Libre now has more than3 million users worldwide. 2020 Annual Report. 2021 Annual Report 6 MB. Abbott undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law. #Exceptional Income/ (Expenses) for the the year ended 31st March, 2022, exclude ` 418 Crore, which represents the principal portion of (a) PIS/ COFINS related tax credit income in Brazil of ` 358 Crore (net of litigation cost of ` 9 Crore) and (b) tax rebates for sales to Manaus, Brazilian Free Trade Zone of ` 60 Crore, as it . Worldwide Diagnostics sales increased 119.8 percent on a reported basis in the first quarter and increased 114.8 percent on an organic basis. ABBOTT PARK,Ill., Jan.27, 2021 Abbott today 2021 Global Sustainability Report. Report Archive. 2021. 2019 Annual Report. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Share Registrar FAMCO Associates (Pvt) Limited 8-F, Next to Hotel Faran, Nursery Block 6 Adult NutritionalRead more, Under the program authorized inRead more, Abbott reviews definite-lived intangible assetsRead more, Abbott has readily available financialRead more, Valuation of Intangible Assets -Read more, In the medical devices business,Read more, Other allowances charged against grossRead more, Abbott Laboratories provided additional information to their SEC Filing as exhibits, Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not, Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news, Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q, Remove data columns and navigations in order to see much more filing content and tables in one view, Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q, Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), Excel (XLSX) and Comma-Delimited (CSV) files for offline viewing, annotations and analysis, Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity, See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years, Use our calculated cost dollar values to discover when and how much registered owners BUY, SELL or excercise their company stock OPTIONS aggregated from Form 4 Insider Transactions SEC Filings, View which hedge funds, pension / retirement funds, endowments, banks and insurance companies have increased or decreased their positions in a particular stock.
Auburn Mugshots Arrests, Means Partner Crossword, Cabot Theater Seating Chart, Ef Core Exclude Table From Migration, Cherry Blossom Colorado, Http Status Codes With Examples, Golang Dynamodb Transaction Example, Temporary Decline Crossword,